W H de Jong - JoVE Visualize

Showing results (21-30 of 62) with videos related to

Pageof 7

Sort By:

Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1986

Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinomaW H de Jong, J S Teppema, S S Wagenaar, et al.

Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1991

Intravesical BCG administration in the guinea pig. II. Immunohistochemical characterization of cellular infiltrate after one or two cycles of intravesical BCGW H de Jong, E C De Boer, A P Van Der Meijden, et al.

Toxicology|October 2, 2001

Comparison of dose-responses of contact allergens using the guinea pig maximization test and the local lymph node assayF M van Och, R J Vandebriel, M K Prinsen, et al.

Toxicology and Applied Pharmacology|January 19, 2000

Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4R J Vandebriel, W H De Jong, S W Spiekstra, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1990

Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pigP A Steerenberg, W H De Jong, E Geerse, et al.

Cancer Research|February 1, 1992

In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude miceU K Nässander, P A Steerenberg, H Poppe, et al.

Cancer Research|October 1, 1983

Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M ratW H de Jong, P A Steerenberg, J G Vos, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regressionP A Steerenberg, W H De Jong, E Geerse, et al.

Journal of the National Cancer Institute|February 1, 1986

Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationshipQ G van Hoesel, P A Steerenberg, J A Dormans, et al.

Urological Research|January 1, 1989

Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pigA P van der Meijden, W H de Jong, E C de Boer, et al.

Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:

Pageof 7

Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1986

Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinomaW H de Jong, J S Teppema, S S Wagenaar, et al.

Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1991

Intravesical BCG administration in the guinea pig. II. Immunohistochemical characterization of cellular infiltrate after one or two cycles of intravesical BCGW H de Jong, E C De Boer, A P Van Der Meijden, et al.

Toxicology|October 2, 2001

Comparison of dose-responses of contact allergens using the guinea pig maximization test and the local lymph node assayF M van Och, R J Vandebriel, M K Prinsen, et al.

Toxicology and Applied Pharmacology|January 19, 2000

Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4R J Vandebriel, W H De Jong, S W Spiekstra, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1990

Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pigP A Steerenberg, W H De Jong, E Geerse, et al.

Cancer Research|February 1, 1992

In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude miceU K Nässander, P A Steerenberg, H Poppe, et al.

Cancer Research|October 1, 1983

Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M ratW H de Jong, P A Steerenberg, J G Vos, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regressionP A Steerenberg, W H De Jong, E Geerse, et al.

Journal of the National Cancer Institute|February 1, 1986

Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationshipQ G van Hoesel, P A Steerenberg, J A Dormans, et al.

Urological Research|January 1, 1989

Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pigA P van der Meijden, W H de Jong, E C de Boer, et al.

Pageof 7